| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.2M | — |
| Cost of Revenue | $7.2M | — |
| Gross Profit | $4.0M | — |
| R&D Expense | $1K | -12.2% |
| SG&A Expense | $2.4M | +1.7% |
| Operating Income | $683K | +125.3% |
| Income Tax | $156K | — |
| Net Income | -$523K | +87.4% |
| EPS (Basic) | $0.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $226K | +8952.2% |
| Accounts Receivable | $3.2M | — |
| Inventory | $1.2M | — |
| Current Assets | $7.5M | +216.8% |
| Total Assets | $18.1M | +104.5% |
| Current Liabilities | $11.4M | +96.5% |
| Total Liabilities | $16.1M | +98.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.2M | -53.5% |
| Investing Cash Flow | -$6K | +99.9% |
| Financing Cash Flow | -$926K | -130.7% |
| EPS (Diluted) | $0.00 | +100.0% |
| Stockholders' Equity |
| $2.0M |
| +168.6% |